We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$4.03B
AUM Growth
+$2.97B
Cap. Flow
+$2.9B
Cap. Flow %
71.99%
Top 10 Hldgs %
10.7%
Holding
1,519
New
915
Increased
303
Reduced
103
Closed
175

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$59.9M
2
GM icon
General Motors
GM
+$57.6M
3
MDLZ icon
Mondelez International
MDLZ
+$49.1M
4
CSCO icon
Cisco
CSCO
+$41.7M
5
MO icon
Altria Group
MO
+$41M

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$20.8M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$20.5M
3
MA icon
Mastercard
MA
+$16.8M
4
ECL icon
Ecolab
ECL
+$16.3M
5
COL
Rockwell Collins
COL
+$15.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.79%
2 Healthcare 14.4%
3 Technology 14.16%
4 Industrials 11.83%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSA
1326
VisionSys AI
VSA
$9.08M
$100K ﹤0.01%
+4
New +$112K
UCFC
1327
DELISTED
United Community Financial Corp
UCFC
$100K ﹤0.01%
18,400
+5,780
+46% +$30.7K
QNST icon
1328
QuinStreet
QNST
$888M
$98K ﹤0.01%
+16,400
New +$100K
EMKR
1329
DELISTED
Emcore Corp
EMKR
$98K ﹤0.01%
+1,800
New +$96.2K
UNXL
1330
DELISTED
Uni-Pixel, Inc.
UNXL
$93K ﹤0.01%
13,300
+2,600
+24% +$15.4K
CORR
1331
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$90K ﹤0.01%
+2,600
New +$87.2K
CBAY
1332
DELISTED
Cymabay Therapeutics
CBAY
$87K ﹤0.01%
+12,500
New +$120K
CAS
1333
DELISTED
A M Castle & Co
CAS
$84K ﹤0.01%
+23,000
New +$118K
CORT icon
1334
Corcept Therapeutics
CORT
$9.72B
$81K ﹤0.01%
+14,400
New +$52.1K
SA
1335
Seabridge Gold
SA
$2.79B
$78K ﹤0.01%
+14,293
New +$111K
TRST
1336
Trustco Bank Corp NY
TRST
$974M
$78K ﹤0.01%
+2,253
New +$76.2K
NMR icon
1337
Nomura Holdings
NMR
$28.4B
$72K ﹤0.01%
+12,300
New +$70.3K
PRMW
1338
DELISTED
Primo Water Corporation
PRMW
$70K ﹤0.01%
13,300
GSL icon
1339
Global Ship Lease
GSL
$1.55B
$67K ﹤0.01%
+1,538
New +$62.9K
PERI icon
1340
Perion Network
PERI
$374M
$64K ﹤0.01%
6,333
SVA
1341
DELISTED
Sinovac Biotech, Ltd
SVA
$51K ﹤0.01%
+10,300
New +$50.7K
EYPT icon
1342
EyePoint Inc
EYPT
$1.05B
$45K ﹤0.01%
+1,140
New +$47.8K
GYRE icon
1343
Gyre Therapeutics
GYRE
$689M
$30K ﹤0.01%
13
MNI
1344
DELISTED
The McClatchy Company Class A Common Stock
MNI
$22K ﹤0.01%
1,186
-3,417
-74% -$83.4K
AHT
1345
Ashford Hospitality Trust
AHT
$21M
-15
Closed -$153K
AIT icon
1346
Applied Industrial Technologies
AIT
$12.8B
-13,749
Closed -$627K
AIV
1347
Aimco
AIV
$384M
-188,946
Closed -$935K
ALG icon
1348
Alamo Group
ALG
$2B
-6,828
Closed -$331K
ALGN icon
1349
Align Technology
ALGN
$12.1B
-21,027
Closed -$1.18M
AMKR icon
1350
Amkor Technology
AMKR
$14.7B
-223,506
Closed -$1.59M

Similar funds

PDT Partners's Q1 2015 Portfolio in Review

As of Q1 2015, PDT Partners held 1,519 positions worth $4.03B, up 282% from $1.05B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

PDT Partners deployed $2.9B of net new capital in Q1 2015, opening 915 new positions and adding to 303 existing holdings. Its largest new stake was Visa: 906,154 shares worth $59.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Mastercard, an estimated $16.8M trimmed.

  • PDT Partners's largest Q1 2015 buy was Visa: 906,154 shares worth $59.3M.
  • PDT Partners added most to LinkedIn Corporation in Q1 2015, an estimated $23.5M increase.
  • PDT Partners's biggest Q1 2015 reduction was Mastercard, cutting an estimated $16.8M.
  • PDT Partners fully exited Cencora in Q1 2015, selling an estimated $20.8M.
  • PDT Partners's ten largest holdings make up 11% of its $4.03B portfolio in Q1 2015.
  • PDT Partners opened 915 new positions and closed 175 in Q1 2015.
  • PDT Partners's portfolio value rose 282% quarter-over-quarter to $4.03B.

Based on PDT Partners's 13F filing for Q1 2015, filed 15 May 2015.